Literature DB >> 23042752

Cytopathologic features of mammary analogue secretory carcinoma.

Justin A Bishop1, Raluca Yonescu, Denise A S Batista, William H Westra, Syed Z Ali.   

Abstract

BACKGROUND: Mammary analogue secretory carcinoma (MASC) is a recently described salivary gland neoplasm that is defined by ETV6-NTRK3 gene fusion. To the best of the authors' knowledge, only rare case reports of the cytopathologic features of MASC have been published to date.
METHODS: A wide variety of archival salivary gland tumors were tested for ETV6 translocation by break-apart fluorescent in situ hybridization. Positive cases with preoperative fine-needle aspiration (FNA) specimens or intraoperative touch preparations were retrieved from the archives of The Johns Hopkins Hospital. All smears were reviewed and the cytologic characteristics were described.
RESULTS: Five cases of MASC with cytopathologic material (4 FNA specimens and 1 touch preparation) were identified. The cases occurred in 3 men and 2 women ranging in age from 21 years to 78 years (mean, 52 years). On the cytologic smears, the MASCs were variably cellular and exhibited 2 different architectural patterns: 1) intact tissue fragments with isomorphic cells arranged in a sheet-like or papillary configuration; and 2) dispersed and dissociated cells with a mostly "histiocyte-like" appearance with large cells containing abundant vacuolated cytoplasm. No matrix tissue or stromal spindled cells were present. The cells did not display acinic differentiation in the form of cytoplasmic zymogen granules. In each case, the preoperative FNA correctly identified a neoplasm, and the most frequent diagnostic considerations were acinic cell carcinoma, mucoepidermoid carcinoma, and pleomorphic adenoma.
CONCLUSIONS: MASC is a newly described salivary gland tumor that should be considered in the differential diagnosis of low-grade salivary gland neoplasms. Its cytologic features overlap considerably with those of other tumors, especially acinic cell carcinoma and mucoepidermoid carcinoma.
Copyright © 2013 American Cancer Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23042752      PMCID: PMC3845462          DOI: 10.1002/cncy.21245

Source DB:  PubMed          Journal:  Cancer Cytopathol        ISSN: 1934-662X            Impact factor:   5.284


  17 in total

1.  Mammary analogue secretory carcinoma of the salivary glands with ETV6-NTRK3 gene fusion.

Authors:  André Fehr; Thomas Löning; Göran Stenman
Journal:  Am J Surg Pathol       Date:  2011-10       Impact factor: 6.394

2.  Relative accuracy of fine-needle aspiration and frozen section in the diagnosis of lesions of the parotid gland.

Authors:  Raja R Seethala; Virginia A LiVolsi; Zubair W Baloch
Journal:  Head Neck       Date:  2005-03       Impact factor: 3.147

3.  Value of fine-needle aspiration cytology of parotid gland masses.

Authors:  P Zbären; C Schär; M A Hotz; H Loosli
Journal:  Laryngoscope       Date:  2001-11       Impact factor: 3.325

4.  A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma.

Authors:  S R Knezevich; D E McFadden; W Tao; J F Lim; P H Sorensen
Journal:  Nat Genet       Date:  1998-02       Impact factor: 38.330

5.  Mammary analog secretory carcinoma of salivary gland origin with the ETV6 gene rearrangement by FISH: expanded morphologic and immunohistochemical spectrum of a recently described entity.

Authors:  Ashton Connor; Bayardo Perez-Ordoñez; Mary Shago; Alena Skálová; Ilan Weinreb
Journal:  Am J Surg Pathol       Date:  2012-01       Impact factor: 6.394

6.  Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity.

Authors:  Alena Skálová; Tomas Vanecek; Radek Sima; Jan Laco; Ilan Weinreb; Bayardo Perez-Ordonez; Ivo Starek; Marie Geierova; Roderrick H W Simpson; Fabricio Passador-Santos; Ales Ryska; Ilmo Leivo; Zdenek Kinkor; Michal Michal
Journal:  Am J Surg Pathol       Date:  2010-05       Impact factor: 6.394

7.  Acinic-cell carcinoma, papillary-cystic variant: a diagnostic dilemma in salivary gland aspiration.

Authors:  Syed Z Ali
Journal:  Diagn Cytopathol       Date:  2002-10       Impact factor: 1.582

8.  Congenital mesoblastic nephroma t(12;15) is associated with ETV6-NTRK3 gene fusion: cytogenetic and molecular relationship to congenital (infantile) fibrosarcoma.

Authors:  B P Rubin; C J Chen; T W Morgan; S Xiao; H E Grier; H P Kozakewich; A R Perez-Atayde; J A Fletcher
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

9.  Fine-needle aspiration biopsy of salivary gland lesions in a selected patient population.

Authors:  Erik G Cohen; Snehal G Patel; Oscar Lin; Jay O Boyle; Dennis H Kraus; Bhuvanesh Singh; Richard J Wong; Jatin P Shah; Ashok R Shaha
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2004-06

10.  Fine-needle aspiration of 154 parotid masses with histologic correlation: ten-year experience at the University of Texas M. D. Anderson Cancer Center.

Authors:  B M Al-Khafaji; B R Nestok; R L Katz
Journal:  Cancer       Date:  1998-06-25       Impact factor: 6.860

View more
  29 in total

Review 1.  Salivary acinic cell carcinoma: reappraisal and update.

Authors:  V Vander Poorten; A Triantafyllou; L D R Thompson; J Bishop; E Hauben; J Hunt; A Skalova; G Stenman; R P Takes; D R Gnepp; H Hellquist; B Wenig; D Bell; A Rinaldo; A Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-12-19       Impact factor: 2.503

2.  Utility of mammaglobin immunohistochemistry as a proxy marker for the ETV6-NTRK3 translocation in the diagnosis of salivary mammary analogue secretory carcinoma.

Authors:  Justin A Bishop; Raluca Yonescu; Denise Batista; Shahnaz Begum; David W Eisele; William H Westra
Journal:  Hum Pathol       Date:  2013-06-14       Impact factor: 3.466

Review 3.  Emerging Gene Fusion Drivers in Primary and Metastatic Central Nervous System Malignancies: A Review of Available Evidence for Systemic Targeted Therapies.

Authors:  Priscilla K Brastianos; Franziska Maria Ippen; Umbreen Hafeez; Hui K Gan
Journal:  Oncologist       Date:  2018-04-27

4.  Diagnostic Approaches for Salivary Gland Tumors with Secretory and Microcystic Features.

Authors:  Ha Young Woo; Eun Chang Choi; Sun Och Yoon
Journal:  Head Neck Pathol       Date:  2017-11-14

5.  Mammary Analog Secretory Carcinoma (MASC) Involving the Thyroid Gland: A Report of the First 3 Cases.

Authors:  Jennifer Dettloff; Raja R Seethala; Todd M Stevens; Margaret Brandwein-Gensler; Barbara A Centeno; Kristen Otto; Julia A Bridge; Justin A Bishop; Marino E Leon
Journal:  Head Neck Pathol       Date:  2016-07-11

Review 6.  Newly described salivary gland tumors.

Authors:  Alena Skalova; Michal Michal; Roderick Hw Simpson
Journal:  Mod Pathol       Date:  2017-01       Impact factor: 7.842

7.  Salivary gland tumor "wishes" to add to the next WHO Tumor Classification: sclerosing polycystic adenosis, mammary analogue secretory carcinoma, cribriform adenocarcinoma of the tongue and other sites, and mucinous variant of myoepithelioma.

Authors:  Douglas R Gnepp
Journal:  Head Neck Pathol       Date:  2014-03-05

8.  Secretory carcinoma - impact of translocation and gene fusions on salivary gland tumor.

Authors:  Ryoko Inaki; Masanobu Abe; Liang Zong; Takahiro Abe; Aya Shinozaki-Ushiku; Tetsuo Ushiku; Kazuto Hoshi
Journal:  Chin J Cancer Res       Date:  2017-10       Impact factor: 5.087

Review 9.  Unmasking MASC: bringing to light the unique morphologic, immunohistochemical and genetic features of the newly recognized mammary analogue secretory carcinoma of salivary glands.

Authors:  Justin A Bishop
Journal:  Head Neck Pathol       Date:  2013-03-05

Review 10.  Mammary analogue secretory carcinoma: update on a new diagnosis of salivary gland malignancy.

Authors:  Roshan Sethi; Elliott Kozin; Aaron Remenschneider; Josh Meier; Paul VanderLaan; William Faquin; Daniel Deschler; Robert Frankenthaler
Journal:  Laryngoscope       Date:  2013-07-09       Impact factor: 3.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.